← back to search

Yao Zhang

University of Arizona · US
Area of research
Molecular Biology · Cardiology and Cardiovascular Medicine
Research interest
Research focused on Mendelian randomization and Ischemia, with related work in Experimental autoimmune encephalomyelitis, Inflammation, Inflammatory bowel disease. Notable publications include 'Therapeutic targets for inflammatory bowel disease: proteome-wide Mendelian randomization and colocalization analyses', 'Role of mitochondrial metabolic disorder and immune infiltration in diabetic cardiomyopathy: new insights from bioinformatics analysis', and 'Depression and 24 gastrointestinal diseases: a Mendelian randomization study'.
h-index
citations
1,197
works
46
NIH funding
primary concept
email

Recent publications

Mechanisms of sorafenib-induced cardiotoxicity: ER stress induces upregulation of ATF3, leading to downregulation of NDUFS1 expression and mitochondrial dysfunction
Frontiers in Pharmacology 2025cited by 5position: lastdoi
Urea functions as a risk signal driving astrocyte-mediated neuroinflammation following stroke
Journal of Neuroinflammation 2025cited by 2position: middledoi
Synergistic potential of bone marrow mesenchymal stem cells and miR181-a combinational therapy against multiple sclerosis
Stem Cell Research & Therapy 2025cited by 2position: middledoi
Predictors and Prognostic Factors of Heart Failure with Improved Ejection Fraction
Reviews in Cardiovascular Medicine 2024cited by 6position: lastdoi
Correlation between systolic blood pressure and mortality in heart failure patients with hypertension
Journal of Hypertension 2024cited by 4position: lastdoi
Therapeutic targets for inflammatory bowel disease: proteome-wide Mendelian randomization and colocalization analyses
EBioMedicine 2023cited by 177position: middledoi
Role of mitochondrial metabolic disorder and immune infiltration in diabetic cardiomyopathy: new insights from bioinformatics analysis
Journal of Translational Medicine 2023cited by 108position: lastdoi
Depression and 24 gastrointestinal diseases: a Mendelian randomization study
Translational Psychiatry 2023cited by 86position: middledoi
SIRT1 mediates the inhibitory effect of Dapagliflozin on EndMT by inhibiting the acetylation of endothelium Notch1
Cardiovascular Diabetology 2023cited by 36position: lastdoi
Sepsis induced cardiotoxicity by promoting cardiomyocyte cuproptosis
Biochemical and Biophysical Research Communications 2023cited by 28position: lastdoi
P38 MAPK activated ADAM17 mediates ACE2 shedding and promotes cardiac remodeling and heart failure after myocardial infarction
Cell Communication and Signaling 2023cited by 28position: lastdoi
Increased serum albumin corrected anion gap levels are associated with increased incidence of new-onset HF and poor prognosis in patients with acute myocardial infarction
Clinica Chimica Acta 2023cited by 20position: lastdoi
The Aldose Reductase Inhibitor Epalrestat Maintains Blood–Brain Barrier Integrity by Enhancing Endothelial Cell Function during Cerebral Ischemia
Molecular Neurobiology 2023cited by 18position: middledoi
Cellular differentiation into hyphae and spores in halophilic archaea
Nature Communications 2023cited by 16position: middledoi
Long Noncoding RNA Gpr137b-ps Promotes Advanced Atherosclerosis via the Regulation of Autophagy in Macrophages
Arteriosclerosis Thrombosis and Vascular Biology 2023cited by 16position: middledoi
Predicting life span of type 2 diabetes patients through alkaline phosphatase and vitamin D: Results from NHANES 1999–2018
Atherosclerosis 2023cited by 13position: middledoi
Higher Peripheral Thyroid Sensitivity Is Linked to a Lower Risk of Heart Failure After Acute Myocardial Infarction
The Journal of Clinical Endocrinology & Metabolism 2023cited by 10position: lastdoi
ATF3 promotes ferroptosis in sorafenib-induced cardiotoxicity by suppressing Slc7a11 expression
Frontiers in Pharmacology 2022cited by 65position: middledoi
Clinical Performance and Quality Measures for Heart Failure Management in China: The China-Heart Failure Registry Study
ESC Heart Failure 2022cited by 27position: middledoi
Low Serum Bicarbonate Levels Increase the Risk of All-Cause, Cardiovascular Disease, and Cancer Mortality in Type 2 Diabetes
The Journal of Clinical Endocrinology & Metabolism 2022cited by 17position: lastdoi
Associations of Serum Vitamin B6 Status and Catabolism With All-Cause Mortality in Patients With T2DM
The Journal of Clinical Endocrinology & Metabolism 2022cited by 15position: lastdoi
Association of the TGFβ gene family with microenvironmental features of gastric cancer and prediction of response to immunotherapy
Frontiers in Oncology 2022cited by 5position: middledoi
Role of mitochondrial metabolic disorder and immune infiltration in diabetic cardiomyopathy: new insights from bioinformatics analysis
Research Square 2022cited by 3position: lastdoi
Additional file 2 of iTRAQ-based proteomic analysis of Deinococcus radiodurans in response to 12C6+ heavy ion irradiation
Open MIND 2022cited by 0position: middledoi
Involvement of microRNA-155 in the mechanism of electroacupuncture treatment effects on experimental autoimmune encephalomyelitis
International Immunopharmacology 2021cited by 17position: middledoi
DHA Plays a Protective Role in Cerebral Ischemia-Reperfusion Injury by Affecting Macrophage/Microglia Type Polarization
SSRN Electronic Journal 2021cited by 1position: firstdoi
MicroRNA‐182 exacerbates blood‐brain barrier (BBB) disruption by downregulating the mTOR/FOXO1 pathway in cerebral ischemia
The FASEB Journal 2020cited by 45position: middledoi
Excess salt intake promotes M1 microglia polarization via a p38/MAPK/AR-dependent pathway after cerebral ischemia in mice
International Immunopharmacology 2020cited by 39position: middledoi
IFN-γ regulates the transformation of microglia into dendritic-like cells via the ERK/c-myc signaling pathway during cerebral ischemia/reperfusion in mice
Neurochemistry International 2020cited by 25position: middledoi
Genome‑wide prioritization reveals novel gene signatures associated with cardiotoxic effects of tyrosine kinase inhibitors
Oncology Letters 2020cited by 12position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

Yilan Li · Ministry of Education of the People's Republic of China16 papers (2018–2025)Guangyou Wang · Ministry of Education of the People's Republic of China14 papers (2013–2025)Qingfei Kong · Ministry of Education of the People's Republic of China11 papers (2013–2025)Lili Mu · Harbin Medical University11 papers (2013–2025)Hulun Li · Ministry of Education of the People's Republic of China10 papers (2013–2025)Tongshuai Zhang · Ministry of Education of the People's Republic of China9 papers (2015–2025)Xueyan Lang · Harbin Medical University8 papers (2022–2025)Dandan Wang · Guangxi Medical University7 papers (2013–2021)Yumei Liu · Harbin Medical University7 papers (2013–2025)Yanxiu Zhang · Harbin Medical University7 papers (2019–2024)Jinghua Wang · Shandong University of Technology5 papers (2013–2021)Xueming Xu · Ministry of Education of the People's Republic of China5 papers (2018–2020)Xijun Liu · Guangdong University of Technology5 papers (2013–2021)Shaohong Fang · Shenzhen Second People's Hospital4 papers (2015–2023)Yixiang Jiang · New York University3 papers (2020–2025)Dandan Zhang · Harbin Medical University3 papers (2019–2022)Bing Zhao · Harbin Medical University3 papers (2023–2024)Cheng Peng · Pennsylvania State University3 papers (2022–2024)Shuijie Li · Harbin Medical University3 papers (2023–2023)Haifeng Zou · Harbin Medical University3 papers (2015–2023)